Galectin-1 is associated with the severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography

• Published in: Scientific reports Vol. 10; no. 1; p. 20683
• Main Authors: Chou, Ruey-Hsing, Huang, Shao-Sung, Kuo, Chin-Sung, Wang, Shen-Chih, Tsai, Yi-Lin, Lu, Ya-Wen, Chang, Chun-Chin, Huang, Po-Hsun, Lin, Shing-Jong
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 26.11.2020; Nature Publishing Group
• Subjects: 692/4019; 692/53; Aged; Aged, 80 and over; Angiography; C-reactive protein; C-Reactive Protein - metabolism; Cardiovascular disease; Cardiovascular System - metabolism; Cardiovascular System - pathology; Congestive heart failure; Coronary Angiography - methods; Coronary artery; Coronary artery disease; Coronary Artery Disease - metabolism; Coronary Artery Disease - pathology; Coronary vessels; Creatinine; Diabetes mellitus; Diabetes Mellitus - metabolism; Diabetes Mellitus - pathology; Female; Galectin 1 - metabolism; Galectin-1; Heart Failure - metabolism; Heart Failure - pathology; Hemoglobin; Humanities and Social Sciences; Humans; Hypertension; Hypertension - metabolism; Hypertension - pathology; Kidney diseases; Male; Medical imaging; Middle Aged; multidisciplinary; Myocardial infarction; Myocardial Infarction - metabolism; Myocardial Infarction - pathology; Renal failure; Renal Insufficiency, Chronic - metabolism; Renal Insufficiency, Chronic - pathology; Science; Science (multidisciplinary); Serum levels; Severity of Illness Index; Vascularization; Ventricle

Galectin-1, a β-galactoside-binding lectin mediating inflammation and neovascularization, is reported to attenuate ventricular remodeling after myocardial infarction. But its role in stable coronary artery disease (CAD) has not been fully elucidated. This study aimed to identify the relationship bet...